$ATR News
Last published 1w ago
- 1w agoATRAPTARGROUP, INC. - EX-99.1Earnings ReleasesForm 8-K - Current report - Item 2.02 Item 9.01
- 1w agoATRAptar Reports Third Quarter 2026 ResultsBusiness WireAptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, dosing and protection technologies, and consumer product dispensing, today reported the following third quarter results for the period ended September 30,
- 2w agoATRTYO:382Aptar Pharma and Stevanato Group Collaborate to Help Accelerate Pre-Filled Syringe System SelectionBusiness WireJoint system-level testing combines Stevanato Group glass syringes with Aptar Pharma elastomer components to provide key data earlier in development and help inform packaging decisions for sensitive biologics and other
- 2w agoATRAptar Pharma Acquires Pulmotree, Expanding Growth Opportunities in Next-Generation Pulmonary Drug DeliveryBusiness WireAcquisition is expected to accelerate development and commercialization of Kolibri™ and expand Aptar Pharma’s respiratory drug delivery platform Aptar Pharma, a global leader in drug delivery, dosing, protection
- 2w agoATRAptar Taps Pharma Packaging Veteran Virginie Maes as President of its Pharma BusinessBusiness WireAptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, dosing and protection technologies, and consumer product dispensing, today announced the appointment of Virginie Maes as President of Aptar Pharma,
- 4w agoATRAptar Announces CE Marking for LuerVax® and Accompanying Spray Divider, Strengthening Support for Vaccine DevelopersBusiness WireMilestone strengthens Aptar Pharma’s support for intranasal vaccine development from clinical studies through commercialization Aptar Pharma, part of AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery,
- 1mo agoATRMorgan Stanley 24th Annual Global Healthcare Conference - APTARGROUP INCEarnings Call TranscriptsOkay, good morning everybody. I'm Daniel Cohen. I am a managing director at Morgan Stanley. It's my pleasure to host this fireside chat with the leadership of Aptar Group. Aptr Group is a global leader in drug delivery a
- 1mo agoATRAptar - 1774185 - APTARGROUP INCEarnings Call TranscriptsOkay, good morning everybody. I'm Daniel Cohen. I am a managing director at Morgan Stanley. It's my pleasure to host this fireside chat with the leadership of Aptar Group. Aptr Group is a global leader in drug delivery a
- 1mo agoATRAptar Pharma and Massachusetts General Hospital Collaborate on Platform to Establish Predictive, Data-Driven Model for Advancing Nose-to-Brain Drug DeliveryBusiness WireGoal is to help pharmaceutical innovators evaluate opportunities earlier and accelerate future central nervous system pipelines AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, dosing and protection
- 2mo agoATRWELLS FARGO 21ST ANNUAL HEALTHCARE CONFERENCE - APTARGROUP INCEarnings Call TranscriptsWelcome to the Wells Fargo Health Care Conference. I am looking up the path to be an entertainer at the Wells Fargo Securities and give guest appearance at the Health Care conference as we have been covering and followin
- 2mo agoATRWELLS FARGO 21ST ANNUAL HEALTHCARE CONFERENCE - APTARGROUP INCEarnings Call TranscriptsWelcome to the Wells Fargo Health Care Conference. I am looking up the path to be an entertainer at the Wells Fargo Securities and give guest appearance at the Health Care conference as we have been covering and followin
- 3mo agoATRAptar Reports Second Quarter 2026 ResultsBusiness WireAptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, dosing and protection technologies, and consumer product dispensing, today reported the following second quarter results for the period ended June 30,
- 3mo agoATRAptar Named One of the World's Most Sustainable Companies by TIME for Third Consecutive YearBusiness WireAptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, dosing and protection technologies, and consumer product dispensing, today announced that it has been named one of the World’s Most Sustainable Companies
- 3mo agoATRAptar Beauty Launches Next-Generation Auto-Loading Dropper Technology for Easier, More Accurate Skincare DosingBusiness WireDermalogica Selects Innovative Technology for its FutureCode Skincare Booster AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, dosing and protection technologies, and consumer product dispensing,
- 3mo agoATRAptar Declares Quarterly DividendBusiness WireAptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, dosing and protection technologies, and consumer product dispensing, today announced that the Board declared a quarterly cash dividend of $0.48 per share.
- 4mo agoATRAptar Named Among Top 100 of America’s Best Companies by TIMEBusiness WireAptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, dosing and protection technologies, and consumer product dispensing, today announced that it has been named one of the America’s Best Companies 2026 by
- 4mo agoATRAptar Releases 2025 Corporate Sustainability ReportBusiness WireAptarGroup, Inc. (NYSE:ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today released its 2025 Corporate Sustainability Report entitled Progress in Motion. The report
- 5mo agoATRAptar Named a CDP Supplier Engagement Leader for the Sixth Consecutive YearBusiness WireRecognized for Continued Supply Chain Collaboration AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, dosing and protection technologies, and consumer product dispensing, was named a CDP Supplier
- 5mo agoATRAptar to Participate in Upcoming Investor ConferencesBusiness WireAptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, dosing and protection technologies, and consumer product dispensing, today announced that it will present at two upcoming investor conferences: Jefferies
- 6mo agoATRAptar Advances Sustainability Features in Luxury Packaging through Patented Reloadable Airless Innovation with ClarinsBusiness WireInnovation wins 2026 DIELINE Award with Clarins Total Eye Lift for ‘Sustainable Design – Health, Body & Beauty' AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, dosing and protection technologies,
- 6mo agoATRAptar 2026 Q1 Results Earnings Call - APTARGROUP INCEarnings Call TranscriptsLadies and gentlemen, thank you for standing by and welcome to APTAR's 2026 First Quarter Results Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question and answer se
- 6mo agoATRAptar Reports First Quarter 2026 ResultsBusiness WireAptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery and consumer product dispensing, dosing and protection technologies, today reported the following first quarter results for the period ended March 31, 2026,
- 6mo agoATRAptar Declares Quarterly DividendBusiness WireAptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, including dosing and protection technologies, and consumer product dispensing, today announced that the Board declared a quarterly cash dividend of $0.48
- 6mo agoATRAptar Recognized as One of America's Climate Leaders by USA Today for the Fourth Consecutive YearBusiness WireAptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, including dosing and protection technologies, and consumer product dispensing, announced today that has been named one of America's Climate Leaders by USA
- 7mo agoATRAptar Digital Health Partners with Enable Injections for enFuse® Companion Digital SolutionGlobeNewswireCINCINNATI, April 08, 2026 (GLOBE NEWSWIRE) -- Aptar Digital Health, a global leader in digital health solutions enhancing the patient experience, and Enable Injections, Inc. ("Enable"), a healthcare innovation company
- 7mo agoATRAptar Digital Health Partners with Enable Injections for enFuse® Companion Digital SolutionBusiness WireDigital solution will be designed to help guide users through injection process Aptar Digital Health, a global leader in digital health solutions enhancing the patient experience, and Enable Injections, Inc.
- 7mo agoATRAptar's Unidose Powder Nasal Delivery System Used in ENA Respiratory Phase II Clinical Study of Investigational INNA‑051 Nasal SprayBusiness WireUse of Aptar Pharma's UDS Powder system supports the development of a next‑generation, virus‑agnostic nasal spray being evaluated for its potential to help protect against symptomatic viral respiratory
- 7mo agoATRAptar Announces Gael Touya as its Next Chief Executive Officer; Stephan B. Tanda to Retire by the End of the YearBusiness WireAptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, dosing and protection technologies, and consumer product dispensing, today announced that Gael Touya, a seasoned global executive with more than 30 years of
- 8mo agoATRAptar's Intranasal Delivery System Used in Phase II Clinical Study for Investigational SPONTAN® Nasal SprayBusiness WireSupporting advancement of complex intranasal therapies through clinical development AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, dosing and protection technologies, and consumer product dispensing,
- 8mo agoATRAptar to Participate in Upcoming Investor ConferencesBusiness WireAptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery and consumer product dispensing, dosing and protection technologies, today announced that it will present at two upcoming investor conferences: The Bank
- 9mo agoATRAptar Reports Fourth Quarter and Annual 2025 ResultsBusiness WireAptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery and consumer product dispensing, dosing and protection technologies, today reported the following fourth quarter results for the period ended December 31,
- 10mo agoATRAptar Announces 2026 Quarterly Conference Call DatesBusiness WireAptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery and consumer product dispensing, dosing and protection technologies, today announced the dates and times of quarterly conference calls for the year. Any
- 10mo agoATRAptar Digital Health and ŌURA Collaborate to Advance Migraine Insights by Connecting Migraine Buddy® with Oura RingBusiness WireThe integration aims to empower millions of users with deeper insights into migraine triggers through biometric signals. Aptar Digital Health, part of AptarGroup, Inc. (NYSE:ATR), a global leader in drug and consumer
- 10mo agoATRMISTAptar's Bidose Nasal System Delivers CARDAMYST™ (etripamil), the First and Only Self-Administered FDA-Approved Nasal Spray for Paroxysmal Supraventricular Tachycardia (PSVT)Business WireNovel treatment for PSVT developed with Milestone Pharmaceuticals Aptar Group, Inc. (NYSE:ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today announced that its
- 11mo agoATRAptar Named One of America's Most Responsible Companies by Newsweek for the Seventh Consecutive YearBusiness WireRanked among the Top 100 Companies AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery and consumer product dosing, dispensing and protection technologies, today announced that it has been named one of
- 11mo agoATRAptar Acquires Sommaplast, a Specialized Provider of Oral Dosing Pharma Packaging SolutionsBusiness WireAptarGroup, Inc. (NYSE:ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today announced that it has acquired Sommaplast, a specialized provider of oral dosing pharma
- 1y agoATRAptar to Present at Jefferies Global Healthcare Conference on November 19, 2025Business WireAptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery and consumer product dosing, dispensing and protection technologies, today announced its participation at the Jefferies Global Healthcare Conference on
- 1y agoATRAptar Reports Third Quarter 2025 ResultsBusiness WireAptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery and consumer product dosing, dispensing and protection technologies, today reported the following third quarter results for the period ended September 30,
- 1y agoATRAptar Digital Health Announces FDA 510(k) Clearance for HeroTracker® Sense, a Connected Add-On Device for Metered-Dose InhalersBusiness WireAptar Digital Health, a global leader in digital health solutions enhancing the patient experience, today announced that the U.S Food and Drug Administration (FDA) has granted 510(k) clearance for HeroTracker®
- 1y agoATRAptar Named Among Top 100 of the 'World's Top Companies for Women 2025' by ForbesBusiness WireAptarGroup, Inc. (NYSE:ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today announced that it has been named a World's Top Companies for Women 2025 by Forbes for the
- 1y agoATRAptarGroup, Inc. (ATR) 2025 Investor Day Call (Transcript)Earnings Call Transcripts
- 1y agoATRAptar Increases Quarterly Dividend by Nearly 7% Signaling Continued Momentum and Long-Term StrengthBusiness WireFollowing an increase of almost 10% a year ago AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, consumer product dosing, dispensing and protection technologies, today declared a quarterly cash dividend
- 1y agoATRAptar Announces 2025 Investor DayBusiness WireAptarGroup, Inc. (NYSE:ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, will host an Investor Day on Tuesday, September 9, 2025. The event will begin at 9:00 a.m.
- 1y agoATRAptarGroup, Inc. (ATR) Q2 2025 Earnings Call TranscriptEarnings Call Transcripts
- 1y agoATRAptar Reports Second Quarter 2025 ResultsBusiness WireAptarGroup, Inc. (NYSE:ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today reported the following second quarter results for the period ended June 30, 2025, as
- 1y agoATRHLNAptar's First Nasal Pump Made with 52% Bio-based Material* now Available with Haleon's Otrivin® BrandBusiness WireThe Freepod® nasal spray pump, globally used with the Otrivin® brand, is now made from 52% bio-based feedstock Aptar Pharma, a global leader in drug delivery and active material science solutions and
- 1y agoATRNew Study Using Aptar's Nasal Drug Delivery System Validates Insulin Nasal Spray to Deliver Alzheimer's Drug Directly to the BrainBusiness WireResearch by Wake Forest University School of Medicine provides a crucial method for future Alzheimer's disease treatment trials and reveals key differences in how the drug is absorbed in people with early cognitive
- 1y agoATRAptar Declares Quarterly DividendBusiness WireAptarGroup, Inc. (NYSE:ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today declared a quarterly cash dividend of $0.45 per share. The payment date is August 14, 2025
- 1y agoATRAptar Named One of the World's Most Sustainable Companies by TIME for Second Consecutive YearBusiness WireAptarGroup, Inc. (NYSE:ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today announced that it has been named one of the World's Most Sustainable Companies 2025 by
- 1y agoATRAptar to Participate in Upcoming Investor ConferencesBusiness WireAptarGroup, Inc. (NYSE:ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today announced that it will present at two upcoming investor conferences: The William Blair